Search Results
Jun 22, 2026, 15:30 ET ANVISA aprova nova opção de imunoterapia subcutânea da MSD para diversos tipos de câncer
Participaram do estudo 377 pacientes com doença em estágio IV, de diferentes subtipos de câncer de pulmão, sem certas alterações genéticas específicas (EGFR, ALK ou ROS1). Eles foram divididos em dois grupos: um recebeu a versão subcutânea do medicamento e o outro, a versão intravenosa, ambos combinados com quimioterapia.
More news about: MSD
Jun 22, 2026, 01:45 ET Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell
metastatic NSCLC who have programmed death ligand 1 (PD-L1) tumor proportion score (TPS)≥1% and are EGFR-negative and anaplastic lymphoma kinase (ALK)-negative has been accepted for review by the NMPA, and has entered the priority review and approval process. As of today, Kelun-Biotech has initiated 9
More news about: Kelun-Biotech
Jun 18, 2026, 08:47 ET A New Zealand Goldfield Is Quietly Becoming a Critical-Minerals Story -- and the Drills Are Running 24/7
Companies mentioned: RUA GOLD Inc. (TSX: RUA) (NZX: RGI) (OTC: NZAUF), Alkane Resources Limited (ASX: ALK) (TSX: ALK), Southern Cross Gold Consolidated Ltd. (TSX: SXGC) (ASX: SX2), Larvotto Resources Limited (ASX: LRV), NevGold Corp. (TSXV: NAU) (OTCQX: NAUFF)On
More news about: USA News Group
Jun 17, 2026, 09:00 ET Alaska Airlines promotes CFO Shane Tackett to President
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines
Jun 16, 2026, 11:00 ET From Cold Brew to Champagne: Alaska and Hawaiian Introduce New Summer Drinks for Every Guest
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines
Jun 16, 2026, 09:00 ET Alaska Airlines breaks ground on new hangar facility at Portland International Airport
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines
Jun 12, 2026, 12:03 ET Inaugural 'Here Comes Summer' Benefit Fuels Lung Cancer Research, Honors Legacy of Donna Summer
was diagnosed in 2017, the future felt very uncertain. My doctors tested my tumor and discovered that I have a specific genetic alteration called ALK-positive. Because researchers had spent years studying that mutation, there was actually a targetable treatment. This treatment has given me time—time to
More news about: Lung Cancer Research Foundation
Jun 10, 2026, 16:00 ET Alaska Airlines teams up with Seattle FIFA World Cup 2026™ Local Organizing Committee to launch a new aircraft livery celebrating summer soccer in Seattle
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK." About Seattle FIFA World Cup 26™ Local Organizing CommitteeSeattleFWC26 is the local organizing committee for Seattle's
More news about: Alaska Airlines
Jun 10, 2026, 12:20 ET Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK
expertise in structure-based small molecule design with key clinical insights from physician-scientists, the company could design highly selective ROS1 and ALK inhibitors that are able to overcome both drug resistance and toxicity," said Joe Pearlberg, PhD, VP, Scientific Affairs at Deerfield and board member
More news about: Deerfield Management Company, L.P.
Jun 09, 2026, 09:30 ET Lung Cancer Research Foundation Announces Request for Proposals Open for ALK-Positive Lung Cancer Research Grant
2026 LCRF Award on Advancing Breakthroughs in ALK-Positive Lung Cancer grant mechanism will focus on the science behind ALK rearrangements as oncogenic drivers of malignancy and/or the development of novel therapeutic approaches for patients with ALK positive lung cancer that have the potential
More news about: Lung Cancer Research Foundation
Jun 03, 2026, 12:00 ET Alaska Air Group announces Mike Sievert, the telecom executive behind T-Mobile's disruptive growth and innovation, will join board of directors
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Air Group
Jun 03, 2026, 08:00 ET Actinium Presents New ATNM-400 Data in KRAS and EGFR Mutant Models at SNMMI 2026 Supporting a Mutation-Agnostic Opportunity In Non-Small Cell Lung Cancer
is also highly heterogeneous: no single mutation dominates, so treatments are fragmented across mutation-specific therapies such as EGFR, KRAS, BRAF, ALK and others, each marketed by different companies, each addressing only a molecular subset, and each ultimately limited by acquired resistance. ATNM-400,
More news about: Actinium Pharmaceuticals, Inc.
Jun 02, 2026, 08:00 ET Alaska Airlines debuts new Lounge in Portland, raising the bar for premium West Coast travel
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Airlines
May 31, 2026, 08:01 ET Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
Phase 3 LIBRETTO-432 results establish RET fusions alongside EGFR mutations and ALK fusions as biomarkers in early-stage lung cancer that are associated with dramatic treatment outcomes, underscoring the importance of comprehensive biomarker testing across all stages of disease
More news about: Eli Lilly and Company
May 30, 2026, 20:00 ET Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
(KEYTRUDA®) as first‑line treatment for locally advanced or metastatic NSCLC who have PD-L1 TPS≥1% and are EGFR-negative and anaplastic lymphoma kinase (ALK)-negative has been accepted for review by the NMPA, and has entered the priority review and approval process. As of today, Kelun-Biotech has initiated 9
More news about: Kelun-Biotech
May 29, 2026, 23:32 ET The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
(KEYTRUDA®) as first‑line treatment for locally advanced or metastatic NSCLC who have PD-L1 TPS≥1% and are EGFR-negative and anaplastic lymphoma kinase (ALK)-negative has been accepted for review by the NMPA, and has entered the priority review and approval process. As of today, Kelun-Biotech has initiated 9
More news about: Kelun-Biotech
May 28, 2026, 13:00 ET Hawaiian Airlines elevates onboard service with pre-order dining by celebrated Hawai'i chefs, fresh fare across all cabins and complimentary local snacks
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Hawaiian Airlines
May 27, 2026, 15:16 ET Alaska Air Group to webcast presentation at 2026 TD Cowen Future of the Consumer Conference
news.alaskaair.com. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as "ALK."
More news about: Alaska Air Group
May 27, 2026, 06:30 ET Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
first-in-human Phase 1/2 clinical trial for patients with advanced ALK-positive NSCLC and other solid tumors. The completed Phase 1 portion enrolled ALK-positive NSCLC patients who previously received at least one ALK TKI, or patients with other ALK-positive solid tumors who had been previously treated or for
More news about: Nuvalent, Inc.
May 22, 2026, 12:26 ET Alaska Airlines treibt die globale Expansion mit der Aufnahme neuer Europastrecken und einer wegweisenden Investition in eine Lounge voran
news.alaskaair.com. Die Alaska Air Group wird an der New Yorker Börse (NYSE) unter dem Kürzel „ALK" gehandelt.FAQ:Fliegt Alaska Airlines nach Europa? Ja. Alaska Airlines bietet jetzt Nonstop-Flüge von ihrem Hauptdrehkreuz
More news about: Alaska Airlines
May 22, 2026, 00:58 ET 2026 ASCO Abstract Highlights | Innovent Announces Preliminary PoC data of IBI363 (PD-1/IL-2α-bias bispecific fusion protein) in Combination with Chemotherapy as First-line Treatment for Advanced NSCLC, Showing Encouraging Efficacy Signals and Favorable Safety
Negative or Low Expression NSCLC Previously untreated patients with locally advanced or metastatic NSCLC, without sensitizing EGFR, ALK, or ROS1 alterations were enrolled in this study. The aim of the study is to evaluate the efficacy and safety of different doses of IBI363 combined with
More news about: Innovent Biologics
May 21, 2026, 20:00 ET Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026
patients with previously untreated locally advanced or metastatic NSCLC without epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) alterations and with programmed death ligand 1 (PD-L1) positive (defined as tumor proportion score (TPS) ≥1%), covering both squamous and non‑squamous
More news about: Kelun-Biotech
May 21, 2026, 17:23 ET Nuvalent Highlights Upcoming Data Presentations for Neladalkib and Zidesamtinib at the 2026 American Society of Clinical Oncology Annual Meeting
investigational, brain-penetrant, ALK-selective inhibitor created with the aim to overcome limitations observed with currently available ALK inhibitors. Neladalkib is designed to remain active in tumors that have developed resistance to first-, second-, and third-generation ALK inhibitors, including tumors
More news about: Nuvalent, Inc.
May 21, 2026, 15:06 ET Alaska Airlines poursuit son expansion mondiale en lançant de nouvelles liaisons européennes et en investissant dans des salons de marque
news.alaskaair.com. Alaska Air Group est coté à la bourse de New York (NYSE) sous le code « ALK ».FAQ :Alaska Airlines dessert-elle l'Europe ? Oui. Alaska Airlines propose désormais, depuis sa principale plateforme
More news about: Alaska Airlines
May 21, 2026, 10:34 ET Alaska Airlines impulsa su expansión global con el lanzamiento de nuevas rutas europeas
news.alaskaair.com. Alaska Air Group cotiza en la Bolsa de Valores de Nueva York (NYSE) con el símbolo "ALK".Preguntas frecuentes:¿Vuela Alaska Airlines a Europa?Sí. Alaska Airlines ahora ofrece vuelos directos desde su centro
More news about: Alaska Airlines